Immunotherapeutic Value of MAP1LC3C and Its Candidate FDA-Approved Drugs Identified by Pan-Cancer Analysis, Virtual Screening and Sensitivity Analysis
Background: The autophagy pathway within the tumour microenvironment can be regulated to inhibit or promote tumour development.In the fight against tumour growth, immunotherapy induces an anti-tumour immune response, whereas autophagy modulates this immune response.A key DIURETIC protein in the autophagy pathway, microtubule-associated protein 1 li